1921
Volume 92, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.14-0662
2015-01-07
2019-06-25
Loading full text...

Full text loading...

/deliver/fulltext/14761645/92/1/1.html?itemId=/content/journals/10.4269/ajtmh.14-0662&mimeType=html&fmt=ahah

References

  1. WHO, 2014. Malaria Vaccine Rainbow Tables. http://www.who.int/vaccine_research/links/Rainbow/en/index.html. Accessed September 3, 2014. [Google Scholar]
  2. Schwartz L, Brown GV, Genton B, Moorthy VS, , 2012. A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J 11: 11.[Crossref] [Google Scholar]
  3. Dutta S, Lee SY, Batchelor AH, Lanar DE, , 2007. Structural basis of antigenic escape of a malaria vaccine candidate. Proc Natl Acad Sci USA 104: 1248812493.[Crossref] [Google Scholar]
  4. Zeeshan M, Alam MT, Vinayak S, Bora H, Tyagi RK, Alam MS, Choudhary V, Mittra P, Lumb V, Bharti PK, Udhayakumar V, Singh N, Jain V, Singh PP, Sharma YD, , 2012. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine. PLoS ONE 7: e43430.[Crossref] [Google Scholar]
  5. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG, Jr Plowe CV, , 2011. A field trial to assess a blood-stage malaria vaccine. N Engl J Med 365: 10041013.[Crossref] [Google Scholar]
  6. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP, , 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 185: 820827.[Crossref] [Google Scholar]
  7. Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, Felgner PL, Doumbo OK, Plowe CV, , 2015. Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. Am J Trop Med Hyg 92: 912.[Crossref] [Google Scholar]
  8. Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traoré K, Niangaly A, Djimdé AA, Doumbo OK, Plowe CV, , 2009. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development. Sci Transl Med 1: 2ra5.[Crossref] [Google Scholar]
  9. Dutta S, Dlugosz LS, Drew DR, Ge X, Ababacar D, Rovira YI, Moch JK, Shi M, Long CA, Foley M, Beeson JG, Anders RF, Miura K, Haynes JD, Batchelor AH, , 2013. Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. PLoS Pathog 9: e1003840.[Crossref] [Google Scholar]
  10. Remarque EJ, Faber BW, Kocken CH, Thomas AW, , 2008. A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits. Infect Immun 76: 26602670.[Crossref] [Google Scholar]
  11. Faber BW, Younis S, Remarque EJ, Rodriguez Garcia R, Riasat V, Walraven V, van der Werff N, van der Eijk M, Cavanagh DR, Holder AA, Thomas AW, Kocken CH, , 2013. Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines. Infect Immun 81: 14791490.[Crossref] [Google Scholar]
  12. Malpede BM, Tolia NH, , 2014. Malaria adhesins: structure and function. Cell Microbiol 16: 621631.[Crossref] [Google Scholar]
  13. Barry AE, Arnott A, , 2014. Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol 28: 359. [Google Scholar]
  14. Kusi KA, Faber BW, Thomas AW, Remarque EJ, , 2009. Humoral immune response to mixed PfAMA1 alleles; multivalent PfAMA1 vaccines induce broad specificity. PLoS ONE 4: e8110.[Crossref] [Google Scholar]
  15. Avril M, Hathaway MJ, Srivastava A, Dechavanne S, Hommel M, Beeson JG, Smith JD, Gamain B, , 2011. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates. PLoS ONE 6: e16622.[Crossref] [Google Scholar]
  16. Simone O, Bejarano MT, Pierce SK, Antonaci S, Wahlgren M, Troye-Blomberg M, Donati D, , 2011. TLRs innate immune receptors and Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) CIDR1α-driven human polyclonal B-cell activation. Acta Trop 119: 144150.[Crossref] [Google Scholar]
  17. Scholzen A, Sauerwein RW, , 2013. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol 29: 252262.[Crossref] [Google Scholar]
  18. Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, Crompton PD, Marsh K, Ndungu FM, , 2013. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol 190: 10381047.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.14-0662
Loading
  • Received : 20 Oct 2014
  • Accepted : 27 Oct 2014
  • Published online : 07 Jan 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error